Gain Therapeutics surges after presenting lab data on lead drug

Gain Therapeutics

12/04/2022 18:51

** Biotech's shares  GANX.O  gain 25% to $5.22, 2nd-top pct
gainer on the Nasdaq
    ** Co presented new pre-clinical lab data from its
Parkinson's Disease program
    ** CEO says data shows "further encouraging disease
modifying potential for patients with Parkinson’s disease who
currently have no effective treatment options"  urn:newsml:reuters.com:*:nGNX3hjd0G
    ** More than 2.2 mln shares traded vs. 67,688 25-DMA volume

 (Reporting by Ankur Banerjee)